April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Antibody Array Analysis of Circulating Growth Factors in Diabetic Retinopathy
Author Affiliations & Notes
  • W. F. Siah
    Ophthalmology, Mater Misericordiae University Hospital, Dublin, Ireland
  • L. Cryan
    UCD Conway Institute, School of Medicine, UCD Conway Institute, Belfield, Ireland
  • C. O'Brien
    Ophthalmology, Mater Misericordiae University Hospital, Dublin, Ireland
  • Footnotes
    Commercial Relationships  W.F. Siah, None; L. Cryan, None; C. O'Brien, None.
  • Footnotes
    Support  National Council for the Blind in Ireland
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1334. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W. F. Siah, L. Cryan, C. O'Brien; Antibody Array Analysis of Circulating Growth Factors in Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2009;50(13):1334.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To determine the circulating levels of multiple angiogenic factors in diabetic patients with varying severity of diabetic retinopathy.

Methods: : The relative levels of multiple growth factors were analysed simultaneously in plasma from 45 patients using an antibody array platform (RayBio® Human Angiogenesis Antibody Array C Series 1000). Plasma from diabetics with no retinopathy (n=14), patients with non-proliferative diabetic retinopathy (n=13), patients with proliferative diabetic retinopathy (n=11) and non-diabetic controls (n=7) was analysed. Enzyme-linked immunosorbant assays (ELISAs) were used to validate changes in the levels of these circulating growth factors.

Results: : Results from antibody array data indicated a positive correlation between severity of diabetic retinopathy and levels of the following angiogenic factors: Growth Regulated Oncogene (GRO)-alpha/CXCL1, Epithelial Neutrophil Activator (ENA)-78/CXCL5, Interleukin (IL)-8/CXCL8, Monocyte Chemoattractant Protein (MCP)-1/CCL2, Regulated on Activation, Normal T-cell Expressed and Secreted (RANTES)/CCL5, Angiogenin, Epidermal Growth Factor (EGF), basic Fibroblast Growth Factor (bFGF), Platelet Derived Growth Factor (PDGF) and Vascular Endothelial Growth Factor (VEGF). Enzyme-linked immunosorbent assays (ELISA) were performed to validate a subset of these results.

Conclusions: : The present study indicates that higher levels of multiple angiogenic factors may be associated with progression of diabetic retinopathy. Some of these factors are novel in the context of proliferative retinopathy including the chemokines CXCL1 and 5.

Keywords: diabetic retinopathy • vascular endothelial growth factor 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.